Peter G. Linde

Corporate Officer/Principal bij Walden Biosciences, Inc.

57 jaar

Health Technology

Finance

Health Services

Actieve functies van Peter G. Linde

Bedrijven	Functie	Begin	Einde
Walden Biosciences, Inc. Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA.	Corporate Officer/Principal	11-10-2022	-

Bedrijven	Functie	Begin	Einde
MORPHIC HOLDING, INC.	Hoofd Techniek/Wetenschap/O&O	17-03-2020	31-12-2021
FIBROGEN, INC.	Corporate Officer/Principal	-	-
ACCELERON PHARMA INC.	Corporate Officer/Principal	-	-

Massachusetts Institute of Technology

Undergraduate Degree

Internationaal

Verenigde Staten

Operationeel

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1
Undergraduate Degree	1

Sectoraal

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	2
MORPHIC HOLDING, INC.	Health Technology
FIBROGEN, INC.	Health Technology

Bedrijven in privébezit	2
Acceleron Pharma, Inc. Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA.	Health Technology
Walden Biosciences, Inc. Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA.	Health Services

Bedrijven in privébezit

Health Technology

Health Services